A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
about
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodiesThe Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressorThe C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.High-resolution functional profiling of a gammaherpesvirus RTA locus in the context of the viral genomeA viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sitesEpstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein.Noise cancellation: viral fine tuning of the cellular environment for its own genome replication.The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinasesRta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency.Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation.Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acidsThe genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.Mechanism for specificity by HMG-1 in enhanceosome assemblyMicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsNucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomesUse of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.Virus and cell RNAs expressed during Epstein-Barr virus replicationThe nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cellsEpstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex.Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
P2860
Q24529499-0BD6FCB5-5CDA-47DB-A655-066290A3D3F6Q24558692-402E3CE7-1F79-41AC-9B36-619B28C2A72FQ24563120-EF12E422-B9DC-46E7-A07E-E43319B82F41Q28343493-55C44F41-B449-48D8-9451-3BE789336FB3Q28480586-C81B8652-9D04-4830-9580-9ECB60E4B9C0Q28590981-AE8CC2EB-2DDC-4B13-A6C8-35921B49C42FQ30450300-8D55FCD1-19EC-4C87-BB9C-C086ADE8DBFEQ33392148-973CCECC-9830-4289-8887-8583E0CCAFEDQ33559699-87647F43-4038-40D7-BA0B-36CB4DEC5F28Q33565012-B2319F09-8C38-4570-A918-3A7D9EC18F9BQ33567052-D38CB01A-83DE-4CDC-8DB4-0CE0E2EE84A6Q33653424-571559BB-D4A5-4FA0-BE79-1E4ADE17B44FQ33653581-3E84421E-A71D-4D43-844C-F47C25E6E265Q33680762-BA161A14-4212-443B-9642-7787ED66C6D1Q33780955-EED1D651-7226-42FB-953E-7393F73617F3Q33785198-DB88567C-9EAD-4CFC-9790-FE767AD28F57Q33787044-C9BBEFBC-D2E8-4EF9-8E7D-8D5785F96C4DQ33793163-567F6A8D-8B33-4682-89BE-472A26BBEE6CQ33802415-5FCF8043-744B-488B-B42D-E169F778B411Q33817088-C3D080CB-03F5-463B-97D7-F04E91B5F108Q33826641-1FCEFE14-E5C8-4716-83E2-269E3CFB9E6AQ33833909-AD0FE9A3-1FC1-4B9F-8196-5E0CE2CDF24FQ33842581-7272A99A-7A8C-46E4-AFD9-06B3877495D3Q33842700-1F8F9019-7B08-4086-A80E-4D7D7537C4C4Q33900360-2B0A44F9-329D-4CFF-A2ED-E2175A35DC20Q33918592-7557895D-6C5D-4524-80CF-FBC0BDE9B370Q33930251-720D08C3-4048-4AD4-B6F5-E3A24841EDE7Q33936163-ED2AC2DB-D60A-41D3-A211-AF30F9DD7E8BQ33957679-11A22E8D-2B9F-475F-9BB9-2FFAD8691D05Q33963973-D7664940-5DF6-4727-8B36-15FF2B60546EQ34059350-49D3E4AF-C130-4968-99FC-4C162172F13AQ34123899-6D464E03-CAF5-40A9-B360-3ACACC922CBEQ34291099-E7438F7A-1440-4EA8-8CDB-F00A5CD02428Q34337317-8146F710-A0AE-4FB3-9ED4-26735D7BBB13Q34350013-19983553-1088-47FC-9C44-914EBA224DD5Q34363413-DDBD7618-59CA-4666-B3F1-1E44353A643FQ34434702-6D755425-37CF-4D7B-A383-D7C77B50E4FEQ34485205-F9724652-F00C-451A-9A4D-A9E5392BDB0AQ34593751-52EBF771-FCBC-43AE-A707-38AFA128AFC0Q34981036-2CA4C5BB-8AF0-4C4A-81C5-723D43591FBD
P2860
A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
A new Epstein-Barr virus trans ...... f a cytoplasmic early antigen.
@en
type
label
A new Epstein-Barr virus trans ...... f a cytoplasmic early antigen.
@en
prefLabel
A new Epstein-Barr virus trans ...... f a cytoplasmic early antigen.
@en
P2093
P2860
P1433
P1476
A new Epstein-Barr virus trans ...... f a cytoplasmic early antigen.
@en
P2093
J M Hardwick
P M Lieberman
S D Hayward
P2860
P304
P407
P577
1988-07-01T00:00:00Z